Keytruda

Moderna ESMO
Biotech

Merck-Moderna vaccine data spur talk of Keytruda-like impact

As the dust settles on data that added $45 billion to Moderna’s market cap, analysts have begun to ask if use of the vaccine be as broad as Keytruda.
Nick Paul Taylor Aug 20, 2026 9:25am
Person throwing piece of paper into full waste bin
Favicon Fierce Pharma

Nature retracts provocative PD-1 time-of-day study

Jun 24, 2026 11:00am
ASCO
Favicon Fierce Pharma

Akeso's 34% overall survival win comes with caveats

May 31, 2026 8:00am
Magnifying glass focusing on womens health

OSE turns up the heat on ovarian cancer with phase 2 win

May 22, 2026 7:14am
lung
Favicon Fierce Pharma

ASCO: Merck, Kelun's sac-TMT combo beats Keytruda by 65% on PFS

May 21, 2026 5:00pm
Graphic image of a pen signing a signature while two strangelooking business people cheer

Merck inks Keytruda supply pact to support Exelixis cancer trial

May 19, 2026 9:38am